Clinical Trials Logo

Esophageal Reflux clinical trials

View clinical trials related to Esophageal Reflux.

Filter by:
  • None
  • Page 1

NCT ID: NCT03375060 Completed - Barrett Esophagus Clinical Trials

Histology Post-Endoscopic Eradication Therapy (EET)

Start date: August 2, 2017
Phase: N/A
Study type: Observational

This study is looking at a cohort of patients who have undergone treatment for Barrett's Esophagus (BE) and who have experienced complete eradication of the disease. The aim of the proposed study is to evaluate the histologic features of the neosquamous epithelium (NSE) following complete eradication of intestinal metaplasia (CE-IM) in patients undergoing routine surveillance biopsies and compare these data to a direct measure of reflux using 24hr pH impedance, to determine the correlation between histology and persistent reflux. These data will allow us to more accurately risk stratify patients for recurrence of BE following EET.

NCT ID: NCT03183310 Not yet recruiting - Esophageal Reflux Clinical Trials

The Effect of Chlorpromazine on Esophageal Sensitivity in Healthy Volunteers.

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The effect of chlorpromazine (Largactil) on esophageal sensitivity will be investigated in this study. Overnight fasted subjects will be asked to fill out 2 questionnaires to assess the emotional status before their onset of the stimulation tests. The multimodal stimulation probe will be positioned through the mouth in the distal esophagus. After the ingestion of the stimulation probe, 10mg of chlorpromazine or placebo (saline) will be slowly administered via intravenous injection. Hereafter the multimodal stimulation tests will be initiated. Esophageal sensitivity will be assessed by performing thermal, mechanical, electrical and chemical stimulation of the esophagus. The chlorpromazine condition will be compared with a placebo condition, this will be organised on 2 separate study visits in a randomised order.

NCT ID: NCT01601379 Completed - Clinical trials for Gastroesophageal Reflux Disease

Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.

PROFILE
Start date: June 2010
Phase: Phase 4
Study type: Observational

The purpose of this observational study (this means that no drug is being tested in this study) is to obtain updated and detailed information about the Gastroesophageal Reflux Disease (GERD) specificities in European patients. The information about patients suffering from typical GERD symptoms will be collected in order to establish a classification of adult patients profile based on the characteristics of GERD symptoms. This study will only involve data collection about the disease. The treatment will not be affected by the study.

NCT ID: NCT01260935 Completed - Clinical trials for Gastroesophageal Reflux Disease

Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures

Start date: November 2002
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effects (good and bad) of the Laparoscopic Hill anti-reflux procedure with the Laparoscopic Nissen anti-reflux surgical procedure to see whether one is better than the other.

NCT ID: NCT00634608 Completed - Obesity Clinical Trials

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

Start date: February 2008
Phase: N/A
Study type: Interventional

The specific aim of this proposed project is to implement a standard process for integrating MedlinePlus health information prescriptions into the clinic workflow. Hypothesis 1: Individuals in the intervention group who receive tailored email health information with provider selected MedlinePlus links and added commentary for patient specific conditions will be more likely to seek information / use MedlinePlus compared with individuals in the control group. Hypothesis 2: Individuals in the intervention group who receive tailored email health information with provider selected MedlinePlus links and added commentary for patient specific conditions will be more satisfied with the information received compared with individuals in the control group.

NCT ID: NCT00222170 Completed - Esophageal Reflux Clinical Trials

Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)

Start date: May 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the production of mucin in GERD/RE subjects before and after 8 weeks of treatment with rabeprazole.